<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9796">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05690022</url>
  </required_header>
  <id_info>
    <org_study_id>EndoFlip</org_study_id>
    <nct_id>NCT05690022</nct_id>
  </id_info>
  <brief_title>The Use of EndoFlip as a Clinical Tool for the Prediction of Postoperative GERD After Sleeve Gastrectomy</brief_title>
  <official_title>The Use of EndoFlip as a Clinical Tool for the Prediction of Postoperative GERD After Sleeve Gastrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Université de Sherbrooke</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine if preoperative EndoFlip measurement can effectively predict&#xD;
      postoperative GERD-related quality of life and lower esophageal acid exposure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Enrolled patients will be subjected to a pre-operative gastroscopy, 48-Hour Bravo pH study&#xD;
      and EndoFlip. In addition, each patient will complete a GERD-related quality of life&#xD;
      questionnaire (GERD-HRQL scale). One year after surgery, patients will undergo a follow up a&#xD;
      gastroscopy, pH study, EndoFlip and the same quality of life questionnaire to predict the&#xD;
      incidence of postoperative GERD and determine the effect of sleeve gastrectomy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2023</start_date>
  <completion_date type="Anticipated">January 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Before/after study design</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>New-onset of gastroesophageal reflux disease</measure>
    <time_frame>12 months postoperatively</time_frame>
    <description>total time of esophageal acid exposure (minutes)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Gastroesophageal Reflux</condition>
  <condition>Sleeve Gastrectomy</condition>
  <condition>Bariatric Surgery Complication</condition>
  <arm_group>
    <arm_group_label>Before sleeve gastrectomy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Gastroesophageal Reflux Disease (GERD) will be evaluated before surgery. EndoFlip, gastroscopy, pH-study and GERD-Health-Related Quality of Life Questionnaire will be realized for all patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sleeve gastrectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After the surgical intervention, new onset or worsening of GERD will be evaluated.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sleeve gastrectomy</intervention_name>
    <description>Patients will be recruited for a sleeve gastrectomy according to the guidelines of the National Institute of Health.</description>
    <arm_group_label>Sleeve gastrectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 18 and 65 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hiatal hernia &gt; 2 cm at preoperative gastroscopy&#xD;
&#xD;
          -  Erosive esophagitis at preoperative gastroscopy&#xD;
&#xD;
          -  Barrett's metaplasia/dysplasia at preoperative gastroscopy&#xD;
&#xD;
          -  Revision surgery before the end of the study&#xD;
&#xD;
          -  Pregnancy during the study period&#xD;
&#xD;
          -  Actively bleeding esophageal varices&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François-Charles Malo</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Sherbrooke</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ringuette Vickie</last_name>
    <phone>15147102044</phone>
    <email>vickie.ringuette@usherbrooke.ca</email>
  </overall_contact>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>December 13, 2022</study_first_submitted>
  <study_first_submitted_qc>January 18, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 19, 2023</study_first_posted>
  <last_update_submitted>January 18, 2023</last_update_submitted>
  <last_update_submitted_qc>January 18, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Laval University</investigator_affiliation>
    <investigator_full_name>Laurent Biertho</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

